| Citation: |
LIU Lijing, MA Hongxin, DU Rui, DI Xiaoling, GU Hua. Effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome and its application in treatment[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 111-114. DOI: 10.7619/jcmp.20221820
|
To observe effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome (NRDS) and its application in treatment of pulmonary surfactant (PS).
The clinical data of 91 children with NRDS were retrospectively analyzed, all children with NRDS were treated with PS. A total of 70 children who underwent physical examinations during the same period were selected as healthy control group. According to the clinical manifestations and X-ray examination results within 6 hours after birth, 91 children in the NRDS group were further divided into mild group (39 cases) and severe group (52 cases). The pulmonary ultrasound manifestations were compared between NRDS group and healthy control group, children with gestational age < 30 weeks and ≥ 30 weeks, and mild group and severe group. The LUS scores at different time points were compared between the mild and severe groups treated by PS.
The detection rates of lung consolidation, air bronchogram, B-line fusion, alveolar interstitial syndrome, pleural line abnormality and pleural effusion in the NRDS group were higher than those in healthy control group (P < 0.05). The detection rate of alveolar interstitial syndrome in children with gestational age < 30 weeks was lower than that in children with gestational age ≥ 30 weeks (P < 0.05). The detection rates of air bronchogram, B-line fusion, pleural line abnormality and pleural effusion in the severe group were higher than those in the mild group (P < 0.05). Before treatment, LUS score of the mild group was lower than that of the severe group (P < 0.05). At 12 and 24 h after treatment, the LUS scores of the two groups were decreased compared with those before treatment, and the LUS scores of the mild group were lower than those of the severe group (P < 0.05).
LUS has an ideal value in the evaluation of NRDS, and can be used as an effective evaluation method for PS treatment of NRD.
| [1] |
臧月珍, 杨阳阳, 吕媛, 等. 不同胎龄新生儿呼吸窘迫综合征早产儿血细胞分析指标及临床特点[J]. 实用临床医药杂志, 2021, 25(1): 69-73. doi: 10.7619/jcmp.20200938
|
| [2] |
赵媛, 刘克战, 张新华. 微创肺表面活性物质给药治疗新生儿呼吸窘迫综合征的临床研究[J]. 中国基层医药, 2020, 27(8): 940-944. doi: 10.3760/cma.j.issn.1008-6706.2020.08.011
|
| [3] |
赵苑竹, 刘丹, 林明名. 肺部超声评分与简化临床肺部感染评分对VAP早期诊断与预后评估的价值[J]. 河北医科大学学报, 2021, 42(6): 698-703. doi: 10.3969/j.issn.1007-3205.2021.06.017
|
| [4] |
陈少军, 陈全景, 周凤霞. 肺表面活性物质联合无创正压通气对新生儿呼吸窘迫的疗效观察及对血气指标的影响[J]. 河北医学, 2020, 26(3): 411-415. doi: 10.3969/j.issn.1006-6233.2020.03.014
|
| [5] |
杨子慧, 李亚超, 于蓓. 肺部超声与胸部X线在新生儿呼吸窘迫综合征中的诊断价值[J]. 临床和实验医学杂志, 2021, 20(24): 2686-2688, 后插1. doi: 10.3969/j.issn.1671-4695.2021.24.031
|
| [6] |
REAMAROON N, SJODING MW, DERKSEN H, et al. Robust segmentation of lung in chest x-ray: applications in analysis of acute respiratory distress syndrome [J]. BMC Med Imaging, 2020, 20(1): 116.
|
| [7] |
王卫卫, 张红伟, 崔清洋, 等. 肺部12分区超声评分法在新生儿呼吸窘迫综合征中的应用价值[J]. 新乡医学院学报, 2022, 39(3): 252-257. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX202203011.htm
|
| [8] |
石永言, 富建华. 《2019年欧洲呼吸窘迫综合征管理指南》解读[J]. 中国实用儿科杂志, 2019, 34(6): 461-465, 516. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201906004.htm
|
| [9] |
顾彩虹, 谢永鹏, 郑涛, 等. 肺部超声评分对腹腔感染机械通气患者脱机结局的预测价值[J]. 中华危重病急救医学, 2020, 32(1): 94-98.
|
| [10] |
中华医学会儿科学分会围产医学专业委员会, 中国医师协会新生儿科医师分会超声专业委员会, 中国医药教育协会超声医学专业委员会重症超声学组, 等. 新生儿肺脏疾病超声诊断指南[J]. 中国当代儿科杂志, 2019, 21(2): 105-113. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201902001.htm
|
| [11] |
沈鸥羽. 不同通气方式对肺泡表面活性物质治疗的呼吸窘迫综合征早产儿脑氧代谢水平的影响[J]. 中国妇幼保健, 2021, 36(20): 4742-4745. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202120033.htm
|
| [12] |
韩晗, 李晓霞, 帅向华, 等. 不同时间肺泡表面活性物质治疗NRDS临床疗效观察[J]. 浙江医学, 2020, 42(12): 1278-1281. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202012014.htm
|
| [13] |
于雅美, 蒋鹏, 姜玉芝, 等. 超声与胸部X线检查对新生儿呼吸窘迫综合征的诊断效能研究[J]. 中国医刊, 2021, 56(6): 633-635. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI202106018.htm
|
| [14] |
左莉莉, 陈辉, 秦振英, 等. 肺部超声在新生儿呼吸窘迫综合征临床诊断及肺泡表面活性物质治疗效果评估中的应用价值[J]. 现代生物医学进展, 2020, 20(19): 3678-3682. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202019015.htm
|
| [15] |
樊静, 谢晓曼, 张传龙. NRDS患儿联合应用NIPPV与PS的临床应用价值及预后效果追踪[J]. 湖南师范大学学报: 医学版, 2021, 18(6): 128-131. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYG202106037.htm
|
| 1. |
柯蕾芬，黄烈平，王吉，顾海红. 不同时机注射枸橼酸咖啡因注射液对新生儿呼吸窘迫综合征患儿血气指标和呼吸暂停的影响. 中国妇幼保健. 2025(02): 259-262 .
| |
| 2. |
吴江云，刘岷，韩菲燕. 肺部超声评分在新生儿呼吸窘迫综合征中的应用效果. 临床心身疾病杂志. 2025(01): 127-131 .
| |
| 3. |
董珊珊，熊梦云. 重症新生儿呼吸窘迫综合征发病的相关影响因素logistic回归分析. 中国医学创新. 2025(06): 149-152 .
| |
| 4. |
林海，姚明明，秦子文，付诗琳，汪红友. 基于肺部超声的预测模型在急性呼吸窘迫综合征中的应用价值研究. 临床和实验医学杂志. 2024(03): 249-253 .
| |
| 5. |
高星辰，侯玮玮，吕媛，杨凯婷，彭娜娜，舒桂华. 床旁即时肺部超声评分在新生儿感染性肺炎呼吸支持治疗方式选择中的应用价值. 实用临床医药杂志. 2024(06): 56-59 .
本站查看
| |
| 6. |
叶桂姣，郝艳萍，王莉萍. 两种不同技术PS给药对NRDS并呼吸困难早产儿肺功能及不良反应的影响. 中国计划生育学杂志. 2024(09): 2079-2084+2089 .
| |
| 7. |
丰晔瑛，王铁岩. INSURE技术联合T-piece治疗新生儿呼吸窘迫综合征的临床有效性. 世界复合医学(中英文). 2024(08): 21-24 .
| |
| 8. |
张志玲，何玉平，马艳. 肺部超声特征及定量评分对NRDS病情的评估. 河南医学高等专科学校学报. 2024(06): 715-718 .
| |
| 9. |
张国清，李薇，陈葵带. 肺部超声技术对新生儿肺部疾病的鉴别诊断价值研究. 中国医药科学. 2024(22): 68-71 .
| |
| 10. |
张国勋，唐利姣，冯云. 肺部超声评分在新生儿呼吸支持中的应用价值. 中国合理用药探索. 2024(12): 88-92 .
| |
| 11. |
胡令英，张俊霞. 肺部超声评分与新生儿呼吸窘迫患儿氧合能力的相关性. 中国处方药. 2023(05): 131-134 .
| |
| 12. |
周蕾，李令民，朱国英. 肺部超声新评分法在新生儿呼吸窘迫综合征用肺泡表面活性物质治疗中的临床疗效. 智慧健康. 2023(35): 9-12 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: